Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterization of Hemostatic Disorders in Septic Shock
NCT02692053Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Feb 2016
- Primary completion
- Feb 2018
01
Overview
Trial (2 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Endogenous Thrombin Potential at 48 hours. Status: unknown.
Beyond the preview
Go deeper on NCT02692053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02692053.